The real world experience of tolvaptan use in patients with autosomal dominant polycystic kidney disease

The outcome of Tolvaptan use in the polycystic kidney disease clinic mirrors the outcome of pivotal data

Authors

Institutions

Publication Details

Journal
Journal of Kidney Care
Published
2024-11-02
DOI
https://doi.org/10.12968/jokc.2024.9.6.276
Primary Topic
Genetic and Kidney Cyst Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The real world experience of tolvaptan use in patients with autosomal dominant polycystic kidney disease

Sarah Borrows, Lukas Foggensteiner, Keita Hirano, Yuki Heath
Journal of Kidney Care
Genetic and Kidney Cyst Diseases
article

The real world experience of tolvaptan use in patients with autosomal dominant polycystic kidney disease

Sarah Borrows, Lukas Foggensteiner, Keita Hirano, Yuki Heath
article en

Abstract

The outcome of Tolvaptan use in the polycystic kidney disease clinic mirrors the outcome of pivotal data

Journal of Kidney CareVol. 9(6)
Metabolism and Renal Physiology (FR), Marymount University (US)
Openalex Percentile: Top 76%
Genetic and Kidney Cyst Diseases
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The real world experience of tolvaptan use in patients with autosomal dominant polycystic kidney disease — Sarah Borrows, Lukas Foggensteiner, et al. · Journal of Kidney Care (2024) | TGRS Research Map | TGRS